Eric Topol hails AI trial methods covered by NYT: "exciting if confirmed"
EricTopol · x · 2026-09-07
Eric Topol amplified a NYT (Cade Metz) story on AI methods in medical trials, calling it exciting especially if confirmed in larger independent studies. Researcher @DrBischof says "these are methods we will use in future trials," involving organ clock and drug dose effects.
Related event: AI-Designed IPF Drug Rentosertib Shows Biological Age Reversal in Trial(18 posts)→
More from Research
- rauchg reproduces OpenAI's covert CPU-channel finding: chat across Firecracker microVMs with no network — ccerrato147 · 2026-10-27
- FlexGlue: sparse-to-dense matching that beats dense accuracy at a fraction of the cost — zhenjun_zhao · 2026-10-27
- Mundo turns a few room photos into an explorable, simulatable 3D world — at 1.5 FPS — mark_k · 2026-10-27
- Mathematics as an experimental science: Marc Lelarge to talk LLM-driven math experiments at ENS — marc_lelarge · 2026-10-27
- DOE Genesis Mission Phase II: AI for particle accelerators and rare isotope separation — prescott · 2026-10-27
- Tenstorrent runs Proteina protein model at high throughput, claims no HBM shortage — gajesh · 2026-10-27